Citadel Advisors’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-91,337
| Closed | -$29.9K | – | 6779 |
|
|
2024
Q3 | $29.9K | Sell |
91,337
-178,367
| -66% | -$58.3K | ﹤0.01% | 5244 |
|
|
2024
Q2 | $124K | Buy |
269,704
+239,558
| +795% | +$110K | ﹤0.01% | 4868 |
|
|
2024
Q1 | $47.6K | Sell |
30,146
-113,694
| -79% | -$180K | ﹤0.01% | 5328 |
|
|
2023
Q4 | $293K | Buy |
143,840
+101,123
| +237% | +$206K | ﹤0.01% | 4256 |
|
|
2023
Q3 | $59.8K | Buy |
+42,717
| New | +$59.8K | ﹤0.01% | 5014 |
|
|
2022
Q2 | – | Sell |
-60,387
| Closed | -$431K | – | 6908 |
|
|
2022
Q1 | $431K | Buy |
60,387
+20,826
| +53% | +$149K | ﹤0.01% | 4594 |
|
|
2021
Q4 | $386K | Sell |
39,561
-1,427,623
| -97% | -$13.9M | ﹤0.01% | 4855 |
|
|
2021
Q3 | $14.6M | Buy |
+1,467,184
| New | +$14.6M | ﹤0.01% | 1121 |
|
|
2021
Q2 | – | Sell |
-14,448
| Closed | -$144K | – | 7100 |
|
|
2021
Q1 | $144K | Buy |
+14,448
| New | +$144K | ﹤0.01% | 5638 |
|